IL308627A - Methods for the treatment of post-infectious autoimmune diabetes - Google Patents
Methods for the treatment of post-infectious autoimmune diabetesInfo
- Publication number
- IL308627A IL308627A IL308627A IL30862723A IL308627A IL 308627 A IL308627 A IL 308627A IL 308627 A IL308627 A IL 308627A IL 30862723 A IL30862723 A IL 30862723A IL 308627 A IL308627 A IL 308627A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- autoimmune diabetes
- treating post
- infectious autoimmune
- post infectious
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192414P | 2021-05-24 | 2021-05-24 | |
| PCT/US2022/030780 WO2022251258A1 (en) | 2021-05-24 | 2022-05-24 | Methods for treating post infectious autoimmune diabetes |
| US17/752,650 US20220372146A1 (en) | 2021-05-24 | 2022-05-24 | Methods for treating post infectious autoimmune diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL308627A true IL308627A (en) | 2024-01-01 |
Family
ID=84104472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL308627A IL308627A (en) | 2021-05-24 | 2022-05-24 | Methods for the treatment of post-infectious autoimmune diabetes |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220372146A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4347021A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024521164A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240023522A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117794572A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022283272A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219473A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308627A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023013849A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022251258A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023013851A (es) | 2021-05-24 | 2023-12-08 | Provention Bio Inc | Metodos para el tratamiento de diabetes tipo 1. |
| US20230382993A1 (en) * | 2022-05-24 | 2023-11-30 | Provention Bio, Inc. | Methods and compositions for preventing or delaying type 1 diabetes |
| TW202506177A (zh) * | 2023-03-30 | 2025-02-16 | 美商普泛森生技公司 | 減少外源性胰島素使用之方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005213449A1 (en) * | 2004-02-04 | 2005-08-25 | The La Jolla Institute For Allergy And Immunology | Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity |
| US20090142338A1 (en) * | 2005-03-04 | 2009-06-04 | Curedm, Inc. | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
| JP2009544761A (ja) * | 2006-06-14 | 2009-12-17 | マクロジェニクス,インコーポレーテッド | 低毒性免疫抑制モノクローナル抗体を用いて自己免疫疾患を治療する方法 |
| WO2015073833A1 (en) * | 2013-11-15 | 2015-05-21 | Pharmacyclics, Inc. | Methods for delaying or preventing the onset of type 1 diabetes |
| JP7137696B2 (ja) * | 2019-05-14 | 2022-09-14 | プロヴェンション・バイオ・インコーポレイテッド | 1型糖尿病を予防するための方法および組成物 |
| WO2021035054A1 (en) * | 2019-08-20 | 2021-02-25 | Precision Biosciences, Inc. | Lymphodepletion dosing regimens for cellular immunotherapies |
| KR20230092863A (ko) * | 2020-06-11 | 2023-06-26 | 프로벤션 바이오, 인코포레이티드 | 제1형 당뇨병을 예방하기 위한 방법 및 조성물 |
| MX2023013851A (es) * | 2021-05-24 | 2023-12-08 | Provention Bio Inc | Metodos para el tratamiento de diabetes tipo 1. |
| US20230382993A1 (en) * | 2022-05-24 | 2023-11-30 | Provention Bio, Inc. | Methods and compositions for preventing or delaying type 1 diabetes |
-
2022
- 2022-05-24 AU AU2022283272A patent/AU2022283272A1/en active Pending
- 2022-05-24 JP JP2023572868A patent/JP2024521164A/ja active Pending
- 2022-05-24 IL IL308627A patent/IL308627A/en unknown
- 2022-05-24 MX MX2023013849A patent/MX2023013849A/es unknown
- 2022-05-24 CN CN202280044277.7A patent/CN117794572A/zh active Pending
- 2022-05-24 WO PCT/US2022/030780 patent/WO2022251258A1/en not_active Ceased
- 2022-05-24 CA CA3219473A patent/CA3219473A1/en active Pending
- 2022-05-24 US US17/752,650 patent/US20220372146A1/en not_active Abandoned
- 2022-05-24 KR KR1020237043749A patent/KR20240023522A/ko active Pending
- 2022-05-24 EP EP22812013.5A patent/EP4347021A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024521164A (ja) | 2024-05-28 |
| US20220372146A1 (en) | 2022-11-24 |
| CA3219473A1 (en) | 2022-12-01 |
| WO2022251258A1 (en) | 2022-12-01 |
| AU2022283272A1 (en) | 2023-12-07 |
| EP4347021A4 (en) | 2025-04-23 |
| EP4347021A1 (en) | 2024-04-10 |
| CN117794572A (zh) | 2024-03-29 |
| MX2023013849A (es) | 2023-12-08 |
| KR20240023522A (ko) | 2024-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3684377T (pt) | Métodos de tratamento de infeção de hepatite b | |
| GB2587032B (en) | Method for designing accelerator hardware | |
| SG11201803578RA (en) | A treatment method for silicon-containing wastewater and the utilization method thereof, and a method for preparing a molecular sieve and the system thereof | |
| SG10201608532PA (en) | Methods, apparatus and devices for authenticating a call session | |
| PL3317335T3 (pl) | Sposób oczyszczania zanieczyszczonych polimerów | |
| PL3943153T3 (pl) | Układ leczenia wychwytem neutronów | |
| IL272791A (en) | Methods for treating muscular dystrophy | |
| PL3849190T3 (pl) | Sposób projektowania składni oraz przyrząd do przeprowadzania kodowania z wykorzystaniem składni | |
| IL286653A (en) | Methods for treating muscular dystrophy with Casimersen | |
| PL3317334T3 (pl) | Sposób oczyszczania zanieczyszczonych polimerów | |
| ZA202001141B (en) | Zeolite after treatment method | |
| SG10202000757YA (en) | Confirming method | |
| GB2580513B (en) | Method for preparing modified molecular sieve | |
| IL277754B1 (en) | A method for the production of spirochetal-converted cyclic ketoanols | |
| IL264485B (en) | A method for the production of cyclic ketones converted in spirochetal | |
| IL234801B (en) | Adjustable ring for blood vessels, means for treating sfs syndrome, an implantable kit including said ring, a pattern and method for making the ring | |
| GB202303660D0 (en) | Proteoform specific process validation | |
| HUE048933T2 (hu) | Szavazási eljárás láncolt aláírásokkal | |
| GB201806736D0 (en) | Method for virus purification | |
| ZA202106319B (en) | Two-stage method for recovering halogenated hydrocarbons | |
| GB202111184D0 (en) | Methods | |
| EP2838249A4 (en) | METHOD, DEVICE AND SYSTEM FOR PROCESSING A LANGUAGE CALL | |
| ZA201505598B (en) | Method, processing modules and system for executing an executable code | |
| EP3560571C0 (fr) | Procede de purification de fructose | |
| HK40109640A (en) | Methods for treating post infectious autoimmune diabetes |